Herrmann O - Search Results

1

Mtss1 is a critical epigenetically regulated tumor suppressor in CML.

Schemionek M, Herrmann O, Reher MM, Chatain N, Schubert C, Costa IG, Hänzelmann S, Gusmao EG, Kintsler S, Braunschweig T, Hamilton A, Helgason GV, Copland M, Schwab A, Müller-Tidow C, Li S, Holyoake TL, Brümmendorf TH, Koschmieder S. Schemionek M, et al. Among authors: herrmann o. Leukemia. 2016 Apr;30(4):823-32. doi: 10.1038/leu.2015.329. Epub 2015 Dec 1. Leukemia. 2016. PMID: 26621336 Free article.

2

Tumor Suppressor Analysis in CML.

Herrmann O, Schemionek M. Herrmann O, et al. Methods Mol Biol. 2016;1465:87-94. doi: 10.1007/978-1-4939-4011-0_8. Methods Mol Biol. 2016. PMID: 27581141

3

Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling.

Kuepper MK, Bütow M, Herrmann O, Ziemons J, Chatain N, Maurer A, Kirschner M, Maié T, Costa IG, Eschweiler J, Koschmieder S, Brümmendorf TH, Müller-Newen G, Schemionek M. Kuepper MK, et al. Among authors: herrmann o. Leukemia. 2019 Aug;33(8):1964-1977. doi: 10.1038/s41375-019-0427-7. Epub 2019 Mar 6. Leukemia. 2019. PMID: 30842608

4

Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia.

Jost E, Lin Q, Weidner CI, Wilop S, Hoffmann M, Walenda T, Schemionek M, Herrmann O, Zenke M, Brümmendorf TH, Koschmieder S, Wagner W. Jost E, et al. Among authors: herrmann o. Leukemia. 2014 Jun;28(6):1227-34. doi: 10.1038/leu.2013.362. Epub 2013 Nov 27. Leukemia. 2014. PMID: 24280869 Free PMC article.

5

Mtss1^(CSC156) mutant mice fail to display efficient Mtss1 protein depletion.

Fahrenkamp D, Herrmann O, Koschmieder S, Brümmendorf TH, Schemionek M. Fahrenkamp D, et al. Among authors: herrmann o. Leukemia. 2017 Apr;31(4):1017-1019. doi: 10.1038/leu.2017.19. Epub 2017 Feb 7. Leukemia. 2017. PMID: 28167834 No abstract available.

6

Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia.

Herrmann O, Kuepper MK, Bütow M, Costa IG, Appelmann I, Beier F, Luedde T, Braunschweig T, Koschmieder S, Brümmendorf TH, Schemionek M. Herrmann O, et al. BMC Cancer. 2019 Jul 4;19(1):658. doi: 10.1186/s12885-019-5871-2. BMC Cancer. 2019. PMID: 31272418 Free PMC article.

7

LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia.

Ma G, Gezer D, Herrmann O, Feldberg K, Schemionek M, Jawhar M, Reiter A, Brümmendorf TH, Koschmieder S, Chatain N. Ma G, et al. Among authors: herrmann o. Mol Carcinog. 2020 Jan;59(1):87-103. doi: 10.1002/mc.23131. Epub 2019 Nov 6. Mol Carcinog. 2020. PMID: 31691359

8

Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.

Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, Schneider A, Schwaninger M. Zhang W, et al. Among authors: herrmann o. J Cereb Blood Flow Metab. 2005 Jan;25(1):30-40. doi: 10.1038/sj.jcbfm.9600004. J Cereb Blood Flow Metab. 2005. PMID: 15678110

9

Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia.

Inta I, Paxian S, Maegele I, Zhang W, Pizzi M, Spano P, Sarnico I, Muhammad S, Herrmann O, Inta D, Baumann B, Liou HC, Schmid RM, Schwaninger M. Inta I, et al. Among authors: herrmann o. J Neurosci. 2006 Dec 13;26(50):12896-903. doi: 10.1523/JNEUROSCI.3670-06.2006. J Neurosci. 2006. PMID: 17167080 Free PMC article.

10

NF-kappaB signalling in cerebral ischaemia.

Schwaninger M, Inta I, Herrmann O. Schwaninger M, et al. Among authors: herrmann o. Biochem Soc Trans. 2006 Dec;34(Pt 6):1291-4. doi: 10.1042/BST0341291. Biochem Soc Trans. 2006. PMID: 17073804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters